eli lily tirzepatide FDA approves tirzepatide, Lilly's new type 2 diabetes drug, and the company shares an estimated price FDA approval for Zepbound (tirzepatide)

A study that was published in JAMAs Ophthalmology noted a significant increase NAION in people taking semaglutide drugs compared to people receiving other treatments for their type 2 diabetes

Insurance companies have been known to discontinue coverage if diabetic targets are reached (HgbA1C, Fasting glucose)

This unique formula activates GLP-1 and CB2 receptors to help reduce appetite, promote faster and longer-lasting fullness, support healthy glucose metabolism and craving control, and enhance mood and energy levels

Not a regular trash can

A: Common side effects of Semaglutide include nausea, vomiting, and diarrhea, which usually diminish over time